Structure Therapeutics Inc.
GPCR
Cena:
$ 39.19
+0.40 (1.03%)
Valuace
70
Růst
23
Zdraví
75
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| FMR LLC | 8.4 mil | 14.20% | -0.01% | 0.02% | 2023-03-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 7.3 mil | 12.26% | -0.02% | 0.07% | 2023-03-31 |
| AVORO CAPITAL ADVISORS LLC | 6.6 mil | 11.07% | -1.27% | 3.11% | 2025-09-30 |
| JANUS HENDERSON GROUP PLC | 5.4 mil | 9.05% | -0.04% | 0.12% | 2023-03-31 |
| DEEP TRACK CAPITAL, LP | 4.3 mil | 7.23% | -1.73% | 3.37% | 2023-03-31 |
| BVF INC/IL | 3.5 mil | 5.84% | -2.83% | 5.31% | 2023-03-31 |
| MORGAN STANLEY | 2.3 mil | 3.89% | 0.00% | 0.01% | 2023-03-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.0 mil | 3.38% | 0.00% | 0.01% | 2023-03-31 |
| PRINCIPAL FINANCIAL GROUP INC | 1.8 mil | 2.96% | 0.00% | 0.05% | 2024-06-30 |
| CAPITAL INTERNATIONAL INVESTORS | 1.6 mil | 2.81% | 0.00% | 0.01% | 2023-12-31 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.6 mil | 2.66% | -0.22% | 0.56% | 2023-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 1.5 mil | 2.59% | -0.01% | 0.52% | 2023-12-31 |
| ORBIMED ADVISORS LLC | 1.5 mil | 2.49% | -0.24% | 1.42% | 2024-06-30 |
| AMERICAN CENTURY COMPANIES INC | 1.4 mil | 2.43% | 0.02% | 0.04% | 2024-03-31 |
| BAKER BROS. ADVISORS LP | 1.4 mil | 2.42% | -0.19% | 0.40% | 2024-09-30 |
| SIREN, L.L.C. | 1.3 mil | 2.24% | -0.46% | 1.78% | 2025-09-30 |
| VESTAL POINT CAPITAL, LP | 1.2 mil | 2.09% | -0.90% | 1.31% | 2024-06-30 |
| CASDIN CAPITAL, LLC | 1.2 mil | 1.98% | -0.79% | 4.29% | 2023-03-31 |
| TCG CROSSOVER MANAGEMENT, LLC | 920.86 tis | 1.57% | 0.66% | 2.12% | 2023-03-31 |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | 878.30 tis | 1.50% | 0.36% | 0.36% | 2025-12-31 |
| CITADEL ADVISORS LLC | 772.52 tis | 1.32% | 0.01% | 0.01% | 2023-03-31 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 767.99 tis | 1.30% | -0.25% | 0.44% | 2023-03-31 |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 750.00 tis | 1.27% | -0.61% | 1.21% | 2025-06-30 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 640.22 tis | 1.08% | -0.85% | 1.82% | 2023-12-31 |
| ALLIANCEBERNSTEIN L.P. | 638.81 tis | 1.08% | 0.00% | 0.01% | 2024-06-30 |
| PARADIGM BIOCAPITAL ADVISORS LP | 545.29 tis | 0.92% | 0.54% | 0.54% | 2025-09-30 |
| FRANKLIN RESOURCES INC | 531.60 tis | 0.90% | -0.01% | 0.01% | 2023-03-31 |
| LOGOS GLOBAL MANAGEMENT LP | 500.00 tis | 0.84% | -1.32% | 1.20% | 2023-03-31 |
| FEDERATED HERMES, INC. | 468.30 tis | 0.81% | -0.03% | 0.02% | 2023-03-31 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 467.80 tis | 0.79% | -0.02% | 0.04% | 2025-12-31 |
| FARALLON CAPITAL MANAGEMENT LLC | 454.00 tis | 0.78% | 0.15% | 0.15% | 2025-12-31 |
| INVESCO LTD. | 443.74 tis | 0.76% | 0.00% | 0.00% | 2023-09-30 |
| BLACKROCK, INC. | 441.98 tis | 0.75% | 0.00% | 0.00% | 2024-09-30 |
| POINT72 ASSET MANAGEMENT, L.P. | 407.70 tis | 0.70% | 0.01% | 0.02% | 2024-06-30 |
| ABRDN PLC | 391.81 tis | 0.66% | 0.00% | 0.03% | 2024-06-30 |
| HANDELSBANKEN FONDER AB | 380.00 tis | 0.66% | 0.00% | 0.03% | 2024-12-31 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 368.55 tis | 0.63% | 0.22% | 0.36% | 2024-09-30 |
| ECOR1 CAPITAL, LLC | 334.38 tis | 0.57% | 1.06% | 1.06% | 2025-12-31 |
| DEUTSCHE BANK AG\ | 331.87 tis | 0.56% | -0.01% | 0.01% | 2025-12-31 |
| BELLEVUE GROUP AG | 315.86 tis | 0.54% | 0.02% | 0.18% | 2023-09-30 |
| NATIONAL BANK OF CANADA /FI/ | 305.40 tis | 0.52% | 0.00% | 0.01% | 2024-09-30 |
| BALYASNY ASSET MANAGEMENT L.P. | 304.93 tis | 0.52% | 0.00% | 0.02% | 2025-03-31 |
| SC CHINA HOLDING LTD | 266.06 tis | 0.45% | -0.91% | 0.38% | 2023-09-30 |
| CAPRICORN FUND MANAGERS LTD | 252.60 tis | 0.43% | 4.23% | 4.23% | 2025-12-31 |
| CATALIO CAPITAL MANAGEMENT, LP | 255.38 tis | 0.43% | -0.54% | 2.57% | 2024-12-31 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 254.97 tis | 0.43% | -0.01% | 0.05% | 2025-12-31 |
| TWO SIGMA ADVISERS, LP | 249.30 tis | 0.43% | 0.01% | 0.01% | 2025-06-30 |
| ALYESKA INVESTMENT GROUP, L.P. | 244.85 tis | 0.42% | 0.02% | 0.02% | 2025-09-30 |
| PENTWATER CAPITAL MANAGEMENT LP | 245.00 tis | 0.41% | 0.06% | 0.06% | 2026-03-31 |
| 245.04 tis | 0.41% | 0.05% | 0.05% | 2026-03-31 | |
| READYSTATE ASSET MANAGEMENT LP | 237.19 tis | 0.41% | 0.17% | 0.28% | 2024-09-30 |
| PARKMAN HEALTHCARE PARTNERS LLC | 232.09 tis | 0.39% | 0.79% | 1.15% | 2025-12-31 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 225.00 tis | 0.38% | 6.03% | 8.82% | 2023-03-31 |
| BANK OF AMERICA CORP /DE/ | 227.13 tis | 0.38% | 0.00% | 0.00% | 2023-06-30 |
| SECTORAL ASSET MANAGEMENT INC | 221.87 tis | 0.38% | 3.13% | 3.83% | 2023-12-31 |
| CAPITAL RESEARCH GLOBAL INVESTORS | 2.2 mil | 0.38% | -0.01% | 0.01% | 2023-09-30 |
| AMERIPRISE FINANCIAL INC | 219.52 tis | 0.37% | 0.00% | 0.00% | 2023-12-31 |
| FORESITE CAPITAL MANAGEMENT VI LLC | 210.00 tis | 0.36% | -1.53% | 2.45% | 2024-12-31 |
| UBS GROUP AG | 212.92 tis | 0.36% | 0.00% | 0.00% | 2023-06-30 |
| JPMORGAN CHASE & CO | 212.80 tis | 0.36% | 0.00% | 0.00% | 2023-09-30 |
| SIO CAPITAL MANAGEMENT, LLC | 209.09 tis | 0.35% | -0.76% | 1.45% | 2025-12-31 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 206.70 tis | 0.35% | 0.00% | 0.00% | 2023-12-31 |
| D. E. SHAW & CO., INC. | 204.79 tis | 0.35% | 0.01% | 0.01% | 2025-03-31 |
| TD ASSET MANAGEMENT INC | 204.76 tis | 0.35% | 0.00% | 0.01% | 2023-03-31 |
| STEMPOINT CAPITAL LP | 200.27 tis | 0.34% | -2.34% | 1.85% | 2025-09-30 |
| PIER CAPITAL, LLC | 197.51 tis | 0.34% | 0.24% | 0.86% | 2023-12-31 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 197.35 tis | 0.34% | 0.19% | 0.52% | 2023-09-30 |
| HIGHVISTA STRATEGIES LLC | 193.00 tis | 0.33% | 1.84% | 3.46% | 2023-09-30 |
| DIADEMA PARTNERS LP | 191.70 tis | 0.33% | 2.30% | 2.30% | 2025-12-31 |
| WOODLINE PARTNERS LP | 190.81 tis | 0.32% | 0.00% | 0.03% | 2023-03-31 |
| IKARIAN CAPITAL, LLC | 183.09 tis | 0.32% | 0.17% | 0.73% | 2024-09-30 |
| ARROWMARK COLORADO HOLDINGS LLC | 188.20 tis | 0.32% | -0.17% | 0.24% | 2023-03-31 |
| TWO SIGMA INVESTMENTS, LP | 181.42 tis | 0.31% | 0.00% | 0.01% | 2025-09-30 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 175.64 tis | 0.31% | 0.01% | 0.67% | 2024-03-31 |
| CORMORANT ASSET MANAGEMENT, LP | 175.00 tis | 0.30% | 0.42% | 0.42% | 2026-03-31 |
| GOLDMAN SACHS GROUP INC | 173.50 tis | 0.29% | 0.00% | 0.00% | 2025-12-31 |
| CANADA PENSION PLAN INVESTMENT BOARD | 167.80 tis | 0.29% | 0.00% | 0.00% | 2025-06-30 |
| MARSHALL WACE, LLP | 168.58 tis | 0.29% | 0.01% | 0.01% | 2023-09-30 |
| MILLENNIUM MANAGEMENT LLC | 168.93 tis | 0.29% | 0.00% | 0.00% | 2023-03-31 |
| SCHONFELD STRATEGIC ADVISORS LLC | 165.43 tis | 0.28% | 0.05% | 0.06% | 2025-06-30 |
| CCG WEALTH MANAGEMENT, LLC | 150.00 tis | 0.26% | 0.09% | 1.64% | 2024-12-31 |
| FIL LTD | 1.2 mil | 0.20% | -0.01% | 0.02% | 2023-09-30 |
| ENSIGN PEAK ADVISORS, INC | 308.24 tis | 0.20% | 0.00% | 0.01% | 2023-09-30 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 216.81 tis | 0.14% | -3.63% | 5.09% | 2024-09-30 |
| EXOME ASSET MANAGEMENT LLC | 151.97 tis | 0.10% | -0.47% | 3.10% | 2024-09-30 |
| CAMBER CAPITAL MANAGEMENT LP | 300.00 tis | 0.05% | 0.00% | 0.18% | 2024-12-31 |
| CANDRIAM S.C.A. | 214.06 tis | 0.04% | -0.01% | 0.02% | 2023-12-31 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 157.96 tis | 0.03% | 0.04% | 0.04% | 2025-03-31 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Lang Matthew | 0 | 0.00 | 23.4 2026 | 0 | ||
| Lang Matthew | officer: COO & GC | A-Award | 184614 | 0.00 | 23.4 2026 | 184614 |
| Lang Matthew | officer: COO & GC | A-Award | 223776 | 18.08 | 23.4 2026 | 223776 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 1367 | 0.00 | 16.4 2026 | 2736 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 16085 | 0.00 | 16.4 2026 | 32171 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 322230 | 16.82 | 23.3 2026 | 322230 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 260217 | 0.00 | 23.3 2026 | 1401593 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | A-Award | 128892 | 16.82 | 23.3 2026 | 128892 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | A-Award | 104085 | 0.00 | 23.3 2026 | 1401656 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | A-Award | 53703 | 16.82 | 23.3 2026 | 53703 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | A-Award | 43368 | 0.00 | 23.3 2026 | 228960 |
| Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | A-Award | 40278 | 16.82 | 23.3 2026 | 40278 |
| Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | A-Award | 32526 | 0.00 | 23.3 2026 | 139917 |
| Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | A-Award | 93984 | 16.82 | 23.3 2026 | 93984 |
| Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | A-Award | 75897 | 0.00 | 23.3 2026 | 280878 |
| Hall Ashley | officer: Chief Development Officer | A-Award | 59073 | 16.82 | 23.3 2026 | 59073 |
| Hall Ashley | officer: Chief Development Officer | A-Award | 47706 | 0.00 | 23.3 2026 | 155187 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 824 | 0.00 | 5.3 2026 | 1824 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | F-InKind | 53454 | 20.99 | 5.3 2026 | 1141376 |
| Hall Ashley | officer: Chief Development Officer | A-Award | 225 | 0.00 | 5.3 2026 | 225 |
| Hall Ashley | officer: Chief Development Officer | A-Award | 237 | 0.00 | 5.3 2026 | 462 |
| Hall Ashley | officer: Chief Development Officer | F-InKind | 4836 | 20.99 | 5.3 2026 | 107481 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | F-InKind | 22305 | 20.99 | 5.3 2026 | 1297571 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | F-InKind | 18735 | 20.99 | 5.3 2026 | 185592 |
| Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | F-InKind | 11313 | 20.99 | 5.3 2026 | 107391 |
| Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | F-InKind | 11826 | 20.99 | 5.3 2026 | 204981 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 20 | 0.00 | 20.1 2026 | 4103 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 552 | 0.00 | 20.1 2026 | 4123 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 330 | 0.00 | 20.1 2026 | 4675 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 465 | 0.00 | 20.1 2026 | 5005 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 230 | 0.00 | 20.1 2026 | 48256 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 6498 | 0.00 | 20.1 2026 | 48486 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 3880 | 0.00 | 20.1 2026 | 54984 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 5477 | 0.00 | 20.1 2026 | 58864 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 15535 | 0.00 | 10.12 2025 | 0 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 1320 | 0.00 | 10.12 2025 | 1 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 1414 | 0.00 | 10.12 2025 | 1321 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 475 | 0.00 | 10.12 2025 | 2735 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 183 | 0.00 | 10.12 2025 | 3210 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 709 | 0.00 | 10.12 2025 | 3393 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 16635 | 0.00 | 10.12 2025 | 15535 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 5589 | 0.00 | 10.12 2025 | 32170 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 2159 | 0.00 | 10.12 2025 | 37759 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 8337 | 0.00 | 10.12 2025 | 39918 |
| Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | F-InKind | 8106 | 7.74 | 22.9 2025 | 216807 |
| Hall Ashley | officer: Chief Development Officer | F-InKind | 6021 | 7.74 | 22.9 2025 | 112317 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | F-InKind | 12846 | 6.84 | 20.8 2025 | 204327 |
| Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | F-InKind | 4470 | 6.84 | 20.8 2025 | 118704 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 26310 | 0.00 | 1.8 2025 | 1515558 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 1000 | 0.00 | 3.7 2025 | 1000 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | F-InKind | 12495 | 7.92 | 3.7 2025 | 1121183 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | F-InKind | 16050 | 6.84 | 3.7 2025 | 1194830 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 89697 | 0.00 | 3.7 2025 | 1210880 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | A-Award | 831 | 0.00 | 3.7 2025 | 2946 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | F-InKind | 5940 | 7.92 | 3.7 2025 | 1287359 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | F-InKind | 7089 | 6.84 | 3.7 2025 | 1319876 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | A-Award | 39606 | 0.00 | 3.7 2025 | 1326965 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | F-InKind | 6441 | 7.92 | 3.7 2025 | 160095 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | A-Award | 57078 | 0.00 | 3.7 2025 | 217173 |
| Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | F-InKind | 1824 | 7.92 | 3.7 2025 | 98715 |
| Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | A-Award | 24459 | 0.00 | 3.7 2025 | 123174 |
| Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | A-Award | 429 | 0.00 | 3.7 2025 | 1157 |
| Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | F-InKind | 1233 | 7.92 | 3.7 2025 | 218355 |
| Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | F-InKind | 1434 | 6.84 | 3.7 2025 | 224913 |
| Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | A-Award | 7992 | 0.00 | 3.7 2025 | 226347 |
| WELCH DANIEL G | director | A-Award | 51804 | 7.37 | 25.6 2025 | 51804 |
| TETLOW SHARON | director | A-Award | 51804 | 7.37 | 25.6 2025 | 51804 |
| DOBMEIER ERIC | director | A-Award | 51804 | 7.37 | 25.6 2025 | 51804 |
| Waldstreicher Joanne | director | A-Award | 51804 | 7.37 | 25.6 2025 | 51804 |
| LOVE TED W | director | A-Award | 51804 | 7.37 | 25.6 2025 | 51804 |
| Russell Angus C. | director | A-Award | 42833 | 7.37 | 25.6 2025 | 42833 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 826890 | 7.02 | 18.3 2025 | 826890 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 340332 | 0.00 | 18.3 2025 | 1133678 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | A-Award | 694 | 0.00 | 18.3 2025 | 1294 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | A-Award | 821 | 0.00 | 18.3 2025 | 2115 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | A-Award | 413445 | 7.02 | 18.3 2025 | 413445 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | A-Award | 170166 | 0.00 | 18.3 2025 | 1293299 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | A-Award | 80829 | 0.00 | 18.3 2025 | 166536 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | A-Award | 196386 | 7.02 | 18.3 2025 | 196386 |
| Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | A-Award | 63810 | 0.00 | 18.3 2025 | 100539 |
| Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | A-Award | 155040 | 7.02 | 18.3 2025 | 155040 |
| Hall Ashley | officer: Chief Development Officer | A-Award | 51048 | 0.00 | 18.3 2025 | 118338 |
| Hall Ashley | officer: Chief Development Officer | A-Award | 124032 | 7.02 | 18.3 2025 | 124032 |
| Coll Crespo Blas | officer: Chief Medical Officer | A-Award | 363 | 0.00 | 18.3 2025 | 728 |
| Coll Crespo Blas | officer: Chief Medical Officer | A-Award | 116988 | 0.00 | 18.3 2025 | 219588 |
| Coll Crespo Blas | officer: Chief Medical Officer | A-Award | 284241 | 7.02 | 18.3 2025 | 284241 |
| FMR LLC | 10 percent owner, other: See Remark 1 | S-Sale | 41 | 0.00 | 10.2 2025 | 0 |
| Coll Crespo Blas | officer: Chief Medical Officer | 33000 | 11.75 | 20.9 2024 | 0 | |
| Coll Crespo Blas | officer: Chief Medical Officer | 3000 | 0.00 | 20.9 2024 | 0 | |
| Coll Crespo Blas | officer: Chief Medical Officer | 100020 | 7.66 | 20.9 2024 | 0 | |
| Coll Crespo Blas | officer: Chief Medical Officer | 55000 | 2.79 | 20.9 2024 | 0 | |
| Coll Crespo Blas | officer: Chief Medical Officer | 0 | 0.00 | 20.9 2024 | 12000 | |
| Coll Crespo Blas | officer: Chief Medical Officer | A-Award | 90600 | 0.00 | 20.9 2024 | 102600 |
| Coll Crespo Blas | officer: Chief Medical Officer | A-Award | 111000 | 12.75 | 20.9 2024 | 111000 |
| Hall Ashley | 0 | 0.00 | 20.9 2024 | 0 | ||
| Hall Ashley | officer: Chief Development Officer | A-Award | 67290 | 0.00 | 20.9 2024 | 67290 |
| Hall Ashley | officer: Chief Development Officer | A-Award | 82890 | 12.75 | 20.9 2024 | 82890 |
| Russell Angus C. | 0 | 0.00 | 28.8 2024 | 0 | ||
| Russell Angus C. | director | A-Award | 75000 | 13.53 | 28.8 2024 | 75000 |
| LOVE TED W | director | A-Award | 33595 | 13.32 | 27.6 2024 | 33595 |
